[HTML][HTML] Stenting versus aggressive medical therapy for intracranial arterial stenosis

…, OO Zaidat, Z Rumboldt, HJ Cloft - … England Journal of …, 2011 - Mass Medical Soc
Background Atherosclerotic intracranial arterial stenosis is an important cause of stroke that
is increasingly being treated with percutaneous transluminal angioplasty and stenting (PTAS…

Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects.

…, JM Mathis, DF Kallmes, HJ Cloft… - American journal …, 1997 - Am Soc Neuroradiology
PURPOSE To describe a technique for percutaneous vertebroplasty of osteoporotic vertebral
body compression fractures and to report early results of its use. METHODS The technique …

Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings

JE Fugate, DO Claassen, HJ Cloft, DF Kallmes… - Mayo Clinic …, 2010 - Elsevier
OBJECTIVE To identify and define clinical associations and radiologic findings of posterior
reversible encephalopathy syndrome (PRES). PATIENTS AND METHODS Patients …

Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis

…, CA Sila, TG Jovin, JG Romano, HJ Cloft - Circulation, 2006 - Am Heart Assoc
Background— Antithrombotic therapy for intracranial arterial stenosis was recently evaluated
in the Warfarin versus Aspirin for Symptomatic Intracranial Disease (WASID) trial. A …

Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial

…, GL Pride, JR Lynch, OO Zaidat, Z Rumboldt, HJ Cloft - The Lancet, 2014 - thelancet.com
Background Early results of the Stenting and Aggressive Medical Management for Preventing
Recurrent stroke in Intracranial Stenosis trial showed that, by 30 days, 33 (14·7%) of 224 …

Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis

W Brinjikji, MH Murad, G Lanzino, HJ Cloft, DF Kallmes - Stroke, 2013 - Am Heart Assoc
Background and Purpose— Flow diverters are important tools in the treatment of intracranial
aneurysms. However, their impact on aneurysmal occlusion rates, morbidity, mortality, and …

Risk of cerebral angiography in patients with subarachnoid hemorrhage, cerebral aneurysm, and arteriovenous malformation: a meta-analysis

HJ Cloft, GJ Joseph, JE Dion - Stroke, 1999 - Am Heart Assoc
Background and Purpose—A well-defined complication rate of cerebral angiography in
patients with subarachnoid hemorrhage (SAH), cerebral aneurysm, and arteriovenous …

A new endoluminal, flow-disrupting device for treatment of saccular aneurysms

…, YH Ding, D Dai, R Kadirvel, DA Lewis, HJ Cloft - Stroke, 2007 - Am Heart Assoc
Background and Purpose— We report a preclinical study of a new endoluminal device for
aneurysm occlusion to test the hypothesis that the device, even without use of intrasaccular …

Collaterals dramatically alter stroke risk in intracranial atherosclerosis

…, JL Saver, MJ Lynn, TN Turan, HJ Cloft… - Annals of …, 2011 - Wiley Online Library
Objective: Stroke risk due to intracranial atherosclerosis increases with degree of arterial
stenosis. We evaluated the previously unexplored role of collaterals in modifying stroke risk in …

Flow diversion for intracranial aneurysms: a review

PI D'Urso, G Lanzino, HJ Cloft, DF Kallmes - Stroke, 2011 - Am Heart Assoc
The introduction of flow diverters for treatment of intracranial aneurysms represents a major
paradigm shift in the treatment of these lesions. The theoretical hallmark of flow diverters is …